Tempus and JW Pharmaceutical Partner on AI-Driven Oncology Research
Key Highlights Tempus partners with JW Pharmaceutical to advance AI-driven cancer research. Utilizes real-world data (RWD) and biological modeling in early-stage…
Browsing Tag
Ryan Fukushima
3 posts
Tempus AI and Remix Therapeutics Expand Strategic Collaboration
Key Highlights Tempus AI and Remix Therapeutics expand their strategic alliance. Remix utilizes Tempus’ multimodal data to advance REM-422 in…
Tempus Unveils AI Integration in Lens Platform
Key Highlights Tempus One technology integrated into the Lens platform, enabling advanced analytics in precision medicine. AI-enabled features for…